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Objectives: One of the main problems in reducing the incidence of oral squamous cell carcinoma (OSCC) is
the inability to appropriately deal with leukoplakia. Accurately identifying lesions which will progress to
malignancy is currently not possible. The present study aims to establish the value of chromosome insta-
bility (CI) detection by DNA image cytometry and FISH analysis for prognosis and monitoring of oral leu-
koplakia.
Materials and methods: For this purpose, we included from our archives 102 oral leukoplakia cases, which
had been diagnosed between 1991 and 2008. Patient follow-up data were collected and the histopathol-
ogical diagnosis was revised. CI assessment was carried out on parafﬁn-embedded tissue sections using
both DNA image cytometry (ICM) and dual target FISH for chromosomes 1 and 7.
Results: 16 of 102 Patients developed carcinoma in situ or OSCC. Both detection methods were found to
yield prognostic information independent of the histopathological diagnosis. CI was a strong individual
marker of progression, with hazard ratios (HRs) of 7.2 and 6.8 for ICM and FISH respectively. Moreover,
this approach seems suitable for monitoring lesions over time (especially ICM). Combining histopathol-
ogy and CI enables subdivision of patients into three risk groups, with different probabilities of malignant
progression.
Conclusion: CI detection seems a reliable method for risk assessment of oral premalignancies and its
application may contribute to a better risk-counselling and appropriate treatment regimen or watch-
full-waiting approach of patients.
 2013 Elsevier Ltd. All rights reserved.Introduction
Oral cancer is the sixth most common malignancy worldwide,
with a yearly incidence of about 274.000 cases [1]. Most oral
tumours are squamous cell carcinomas (SCCs) with smoking and
alcohol consumption as major risk factors [1,2]. In contrast to can-
cers of the breast, colon, prostate and melanoma that are showing
a signiﬁcantly better prognosis due to improvements in early
detection and therapy [3], the survival rate of patients with oral
squamous cell carcinomas (OSCCs) has not increased substantially
over the last decades [2,4]. The oral cavity and oropharynx areeasily accessible for visualization, which may facilitate early diag-
nosis of (pre)malignant lesions. Nevertheless, in spite of advances
in surgical and other treatment modalities, the 5-year survival rate
of OSCC remains only approximately 50% [2,3]. This lack of
progress can partially be explained by our inability to adequately
recognize early developed OSCC as well as precursor lesions at risk
for progression [3].
Oral leukoplakia and, to a lesser degree, erythroplakia are rela-
tively common lesions of the oral mucosa, some of which are at
risk for malignant transformation [5]. In particular, the borders of
the tongue and the ﬂoor of the mouth have been mentioned as
high-risk sites [6]. Whereas oral erythroplakia show malignant
transformation in almost all cases, oral leukoplakia eventually pro-
gress to malignancy in an estimated 1.1–17.5% [7]. Therefore, espe-
cially discrimination between potentially malignant leukoplakias
and non-harmful lesions is of key importance.
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sor lesions (i.e. dysplastic and non-dysplastic) is insufﬁciently
accurate to predict their malignant potential [8]. In addition, histo-
pathological classiﬁcation is hampered by observer variability
[9,10]. and sampling variability [11]. Therefore, more effective
methods for the assessment of the malignant potential of oral leu-
koplakia are urgently needed [12]. It is widely believed that insta-
bility of the genome is the driving force behind the development of
the majority of human epithelial cancers [13]. CI may be detected
by different molecular biological approaches. DNA content analysis
using image cytometry (ICM) or ﬂow cytometry (FCM) are
frequently used techniques [4,14–17]. Three recently published
retrospective studies have shown that ICM is able to identify
patients with dysplasias that are more likely to progress to OSCC
[14,16,17]. FCM displays an increasing degree of aneuploidy in
the spectrum of lesions ranging from healthy oral mucosa, non-
dysplastic and dysplastic leukoplakia to OSCC [15]. Alternatively,
copy number alterations of individual chromosome loci can be
studied using ﬂuorescence in situ hybridization (FISH) analysis
[18–21]. Several studies on FISH for chromosomes 1 and 7 revealed
that numerical chromosome aberrations have a predictive value in
the progression of oral precursor lesions to SCC [18,19,22].
The aim of the present study was to establish the value of CI
detection by means of both ICM and FISH in comparison with rou-
tine histopathological assessment for the risk assessment of oral
precursor lesions in a series of 102 leukoplakia. In addition, we
evaluated both essays for their reliability to monitor possible pro-
gression of premalignant lesions over time.Materials and methods
Patient selection
This retrospective study included patients who were admitted
to the department of Oral and Maxillofacial Surgery at the Radboud
University Nijmegen Medical Centre (RUNMC), The Netherlands,
between 1991 and 2008 for evaluation of suspicious lesions of
the oral mucosa. The minimal follow-up time was 6 months.
Patients with oral hyperplastic or dysplastic lesions were identiﬁed
using the Dutch Pathology diagnosis and registration system
(PALGA). Patients who had been previously treated for malignancy
as well as patients with a histologically conﬁrmed carcinoma
in situ at ﬁrst biopsy were excluded. Clinical data including age,
etiological factors, localization, type of treatment (surgery, laser
ablation or expectative policy) were obtained from the patients’
medical charts. Only patients with a complete data-set were
included, resulting in 102 specimens (of 102 patients). Data collec-
tion was performed in accordance with local ethical guidelines.
ICM and FISH analyses were performed on biopsy specimens
obtained at the time of the ﬁrst diagnosis of leukoplakia and on
specimens from eventually developed carcinoma (carcinoma
in situ or invasive carcinoma). The time between consecutive
lesions was set at a minimum of 6 months in order to exclude
synchronous lesions. To assess the value of ICM and FISH for the
monitoring of lesions over time, subsequent premalignant lesions
and recurrent malignancies were analysed.
For each case of leukoplakia and SCC ﬁrst a 4 lm thick slide was
cut from a parafﬁn-embedded specimen for Haemotoxylin-eosin
(HE) analysis followed by three 50 lm and two 4 lm sections for
ICM and FISH respectively and ending again with one 4 lm slide
for HE analysis. The ﬁrst and last slides of the initial leukoplakia
were haematoxylin-eosin stained and revised by an experienced
pathologist (PJS). In this manner it could be assured that both
ICM and FISH analysis were performed on representative areas,
to enhance the accuracy of the test.DNA ploidy measurement of isolated nuclei from tissue sections
Two to four 50 lm thick parafﬁn-embedded sections were used
to isolate cell nuclei according to well-established procedures [10].
A thickness of 50 lm was shown to minimize the number of arte-
facts in DNA histograms [23]. Sections were deparafﬁnised and
rehydrated as follows: xylene (three times 15 min), 100% ethanol
(twice), 96% ethanol (twice), 70% ethanol, 40% ethanol, distilled
water and phosphate-buffered saline (PBS) at least 10 min in each
solution. The tissue sections were transferred into a centrifuge
tube and incubated with 0.5% pepsin (Sigma Aldrich, St Louis,
MO, USA) in PBS (pH 1.50) at 37 C, for 60 min. After enzymatic
digestion, 4 ml of ice-cold PBS was added to stop the reaction. Next
the tissue suspension was ﬁltered through a CellTrics ﬁlter with
50 lm pore size to separate nuclei from tissue debris. After centri-
fugation (1000 rpm, 10 min), 2 ml PBS was added and the amount
of nuclei was counted with a cell-counting device (Z1 Coulter Par-
ticle Counter, Beckman Coulter Inc., Woerden, The Netherlands).
The cell suspension was diluted until the right concentration,
(20,000 cells) was reached, to form a monolayer in a cytospin-cen-
trifuge (10 min 700 rpm), air dried, and ﬁxed in Böhm ﬁxative for
1 h, hence a mixture of 85% methanol absolute, 10% formaldehyde
(37%), and 5% acetic acid (96%). Slides were air dried after twice
rinsing in methanol absolute.
Feulgen staining
First the cell preparations were hydrolysed in 5 M HCl under
controlled temperature at 25 C for 1 h, after which the process
was stopped using distilled water. Thereupon the isolated nuclei
were stained by the Schiff method [10] (Merck, Darmstadt, Ger-
many) for 1 h at room temperature. Next the slides were rinsed
in streaming tap water for 20 min, dehydrated in increasing con-
centrations of ethanol, xylol and mounted in Permount (Thermo
Fisher Scientiﬁc, Landsmeer, The Netherlands).
Measurement of DNA content
All measurements were performed using the Leica QPath Image
Cytometry Workstation (Leica Microsystems GmbH, Wetzlar, Ger-
many) according to an established protocol [10]. Slides of stained
cell nuclei were analysed using a microscope equipped with a
550-nm green ﬁlter and a computer controlled stage. Each mono-
layer contained at least 1500 sampled nuclei. The QPath software
measures the Feulgen integrated optical density (IOD) of individual
nuclei while avoiding the measurement of overlapping, folded, or
clumped cells. ICM analysis of all histological specimens was per-
formed in a blinded fashion at the RUNMC. DNA ploidy histograms
were visually classiﬁed independently by two experienced observ-
ers (JvdL; IOH). In all cases of discrepancy, a consensus classiﬁca-
tion was reached by the same two observers.
In the present study, a diploid histogram is deﬁned by a single
dominant 2c peak (representing G0/G1 phase cells) and possibly a
4c peak (G2 phase cells) not exceeding 10% of the total number
of nuclei (Fig. 1A). If the number of nuclei with a DNA content
>5c exceeded 1% of the total number of cells, the histogram was
classiﬁed as aneuploid. Also, a histogram was classiﬁed as aneu-
ploid if there was a clear and distinct peak outside the 2c/4c re-
gions (Fig. 1B). A lesion was deﬁned as tetraploid if the number
of 4c nuclei exceeded 10% of the total number of epithelial cells
and a 8c peak was observed. The measurements were performed
according to previous published guidelines [24]. Because in some
cases the coefﬁcient of variation (CV: standard deviation of the
2c peak divided by the mean, given in percent) slightly exceeded
the advised threshold of 5%, CVs up to 6% were allowed in the pres-
ent study.
Figure 1. A, B Examples of ICM ploidy histograms A. diploid pattern, B. typical aneuploid pattern. C, D Representative examples of FISH results using centromere probes
speciﬁc for chromosome 1 (green) and 7 (red) in cell nuclei (blue) of head and neck oral mucosa epithelium. C. Nuclei showing disomy for both chromosomes. D. Nuclei
showing an imbalance between the copy number of chromosomes 1 (maximal 4 copies) and 7 (maximal 6 copies).
Table 1
Patient characteristics based upon primary premalignancies.
Patient data Malignant
Transformation
No Yes
Number of patients 86 16
Age Mean (years) 51.9 57.8
CI (95%) (49.6–54.2) (50.9–64.7)
Sex Female 41 7
Male 45 9
Smoking Yes 54 9
No 32 5
In history 9 1
Data NA 2 1
Alcohol Yes 39 7
No 40 8
Data NA 4 1
Follow-up Median (months) 98.0 27.0
CI (95%) (84.8–104.6) (23.7–70.8)
NA = not available.
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specimens
FISHwas performed at theUniversity ofMaastrichtMedical Cen-
tre, Department of Molecular Cell Biology. The procedure was per-
formed as described previously [10,25]. Brieﬂy, 4 lm thick
parafﬁn-embedded tissue specimens were ﬁrst deparafﬁnised and
pretreated with 85% formic acid/0.3% H2O2 at room temperature
1 M sodium thiocyanate (NaSCN) at 80 C and 0.4 g pepsin (800–
1200 U/mg protein porcine stomach mucosa (Sigma Aldrich, St
Louis, MO, USA) per ml 0.02 NHCl at 37 C. Slides were post-ﬁxed
with1% formaldehyde in PBS anddehydratedwith an ascending ser-
ies of ethanol. The probes for chromosome 1 and 7were prepared by
labellingwith biotin- anddigoxigenin-dUTPs anddissolved at a con-
centration of 1 ng/ll in 60% formamide, 2 standard saline citrate
(SSC, pH 7.0), 10% dextran sulphate, and 50 times excess of carrier
DNA (salmon testis DNA; Sigma Chemical Co., St. Louis, MO). After
denaturation of probe and tissue at 80 C for 5 min and overnight
hybridization the tissue specimens were washed stringently in 2
SSC containing 0.05% Tween-20 (Acros Organics, Geel, Belgium)
two times for 5 min at 42 C, followed by 0.1  SSC two times for
5 min at 60 C and 4  SSC/0.05% Tween-20 at room temperature.
Detection of the hybridised probes was established with the fol-
lowing antibody combinations diluted in 4  SSC containing 5%
non-fat dry milk powder: FITC-labeled avidin (Vector, 1:100)/
anti-digoxigenin monoclonal antibody (1:200, Mannheim); Biotin-
ylated Goat Anti-Avidin (Vector, 1:100)/rabbit anti mouse TRITC
(Vector, 1:1000) and FITC-labeled avidin (1:100)/swine anti rabbit
TRITC (Vector, 1:100). Following the ﬁnal wash and dehydration,
slides were mounted in Tris glycerol, containing 2% DACO Antifade
(Glostrup, Denmark) and 0.5 lg/ml of the nuclear DNA counter-
stain DAPI. An example of FISH results is shown in Fig. 1C and D.
Evaluation of the FISH results was carried out as described in our
previous studies [10,22,25].
Data analysis
Clinical data, histopathological characteristics and ICM and FISH
scores of all lesions were statistically analysed using SPSS version17.0.1 software (SPSS Inc., Chicago, USA). The progression into car-
cinoma was analysed using uni- and multivariate Cox regression
analyses and hazard ratios (HRs) including its 95% conﬁdence
intervals (CIs) and associated p-values were calculated. Cumulative
progression towards malignancy analysis was performed by means
of the Kaplan Meier method. In all analyses the p-value for signif-
icance was set at 0.05. To assess the degree of agreement between
ICM and FISH r-statistics were calculated.Results
Patient characteristics and outcome
Of the 102 patients diagnosed with leukoplakia, 48 (47%) were
female and 54 (53%) were male (Table 1). The duration of follow-
up after the ﬁrst biopsy ranged from 6 to 246 months (median
91.5). Malignant progression occurred in 16 patients (5 developed
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up time of these patients was 27.0 months (range: 7–151).
Progressive lesions were located on the ﬂoor of mouth (n = 2),
tongue (n = 10), buccal mucosa (n = 3) and inferior alveolar rim
(n = 1). Carcinomas developed at the same location as the preced-
ing leukoplakias (n = 13), or within a range of 2 cm of the initial
lesion (n = 3) (Warren and Gates criteria) [26].
Clinical parameters
Table 3 gives an overview of the HRs of different clinical param-
eters. Location was associated with risk of malignant development:
leukoplakia of the ﬂoor of mouth or tongue had a signiﬁcantly
higher risk of malignant progression (HR = 3.2; p = 0.047). Older
patients were slightly more susceptible to malignant transforma-
tion with a HR of 1.1 (p = 0.025). No correlation was found between
the type of treatment and developed SCC (data not shown).
Histopathology
An overview of the histological diagnosis for each case of leuko-
plakia related to malignant progression can be found in Table 2
(ﬁrst two columns). Because of the low number of severe dyspla-
sias (n = 3), in the present study these lesions were pooled with
moderate dysplasias for further analyses. This is in accordance
with the review by Warnakulasuriya et al. [27]. In univariate Cox
regression, histopathological diagnosis was associated with malig-
nant transformation with a hazard ration (HR) of 6.3 (CI: 2.3–17.3;
p < 0.001; Table 3) comparing the combination of hyperplasia and
mild dysplasia with moderate and severe dysplasia. Fig. 2 shows
the corresponding survival curves.
Chromosome instability
As tetraploid lesions (n = 3 for both ICM and FISH) harbour an
abnormal DNA content [28–30], these lesions were included in
the aneuploid group. ICM analysis revealed 23 aneuploid vs 79 dip-
loid lesions (23%) and FISH showed 17 aneuploid vs 85 diploid le-
sions (16%). Comparison of FISH and ICM revealed an identical
outcome in 90 out of 102 leukoplakia (Table 4). The kappa statistic
for this comparison was 0.63, which indicates a substantial agree-
ment between both methods. (CI: 0.44–0.82). The percentage of
aneuploidy increased with advancing histopathological classiﬁca-
tion. Of the aneuploid lesions detected by respectively ICM and
FISH, 10 of 23 (43.5%) and 8 of 17 (47.1%) showed malignant pro-
gression. In contrast, only 6 out of 79 (7.6%) and 8 of 85 (9.4%) of
diploid leukoplakia showed malignant progression for ICM and
FISH, respectively (Table 2).
Univariate Cox regression analysis revealed an increased risk of
malignant progression for aneuploid lesions (both ICM (HR = 7.2;
p < 0.001) and FISH (HR = 6.8; p < 0.001); Table 3). This is also
reﬂected in the progression-free survival curves based on CI
detection, showing a signiﬁcantly shorter survival for aneuploid
lesions (Figs. 3 and 4). Including both FISH and ICM in multivariateTable 2
Fraction of hyperplastic and dysplastic lesions transformed into malignancies.
Histopathology Number of SCC
after leukoplakia
Number of SCC after diploid
leukoplakia (ICM)
Number of SC
aneuploid leu
All 16/102 (15.7%) 6/79 (7.6%) 10/23 (43.5%)
HP 5/66 (7.6%) 4/59 (6.8%) 1/7 (14.3%)
D+ 3/16 (18.8%) 0/11 (0.0%) 3/5 (60.0%)
D++ 7/17 (41.2%) 2/9 (22.2%) 5/8 (62.5%)
D+++ 1/3 (33.3%) 0/0 (0.0%) 1/3 (33.3%)
HP = hyperplastic; D + = mild dysplasia; D++ = moderate dysplasia; D+++ = severe dysplaCox regression analysis showed decrease of the HR for both tech-
niques (ICM: HR = 4.2; p = 0.052 respectively FISH: HR = 2.3;
p = 0.240; Table 3) for ICM and FISH, respectively), indicating that
both techniques yield comparable information.
Combining histopathology and CI
In multivariate Cox regression analysis, ICM adjusted for histo-
pathology showed a HR of 5.4 (CI: 1.82–15.8; p = 0.002; Table 3). In
this analysis histopathology and ICM appeared to be rather inde-
pendent, complementary factors. Therefore, multivariate analysis
was also performed by comparing 4 combined classes i.e.: low-
grade diploid, high-grade diploid, low-grade aneuploid and high-
grade aneuploid lesions (high grade being deﬁned as moderate or
severe dysplasia, low grade encompassing the other histopatho-
logic categories). Taking diploid low grade lesions as the reference
category, the HR of aneuploid high-grade lesions was found to be
as high as 22.0 (CI: 5.78–83.45); p < 0.001), with lesions being
either high-grade diploid or low-grade aneuploid showing HR of
4.3 (CI: 0.76–23.92; p = 0.101) and 5.5 (CI: 1.37–21.96; p = 0.016),
respectively (Table 5). Because the latter two groups showed com-
parable HRs they were combined in progression-free survival anal-
ysis (Fig. 5).
FISH adjusted for histopathology showed a HR of 4.4 (CI: 1.5–
13.1; p < 0.01; Table 3). Combining histopathology and FISH in
multivariate Cox regression in a manner comparable to that de-
scribed above for ICM and histopathology, similar results were ob-
tained (Table 5). Aneuploid high-grade lesions show a HR of 16.3
(CI: 3.90–68.18; p < 0.001) compared to low grade diploid lesions,
with lesions being either high-grade diploid or low-grade aneu-
ploidy showing HR of 9.0 (CI: 2.21–36.9; p = 0.002) and 10.1 (CI:
2.52–40.4; p = 0.001). When the latter two groups were combined
a HR of 9.5 (CI: 2.85–32.00; p < 0.001) was found in progression-
free survival analysis as compared to low grade diploid lesions,
but was not signiﬁcantly different from aneuploid high-grade le-
sions (HR 1.71 with CI: 0.49–6.0; p = 0.40).
Monitoring
ICM revealed that almost all aneuploid malignancies resulted
from aneuploid precursor lesions (9 out of 10) and almost all dip-
loid carcinoma had a diploid precursor lesion (5 out of 6; FISH
showed more variability: 4/8 respectively 5/8). Interestingly, two
aneuploid leukoplakias developed after 9.3 and 12.6 years into an
aneuploid SCC (based on ICM).
Also analysis of intermediate precursor lesions and recurrent
SCC was performed (Tables 6 and 7). From seven initial premalig-
nancies showing progression to SCC, subsequent biopsies were
available. Leukoplakia and subsequent malignancies were consid-
ered to be related if they were found at the same mucosal location.
Six of seven cases (ICM-based) showed that the ploidy status of
the successive lesions (both premalignant lesions and SCC) was
identical to the status of the initial lesion. Only one initial aneu-
ploid leukoplakia was followed by both a diploid leukoplakia andC after
koplakia (ICM)
Number of SCC after diploid
leukoplakia (FISH)
Number of SCC after
aneuploid leukoplakia (FISH)
8/85 (9.4%) 8/17 (47.1%)
4/63 (6.3%) 1/3 (33.3%)
0/11 (0.0%) 3/5 (60.0%)
3/10 (30.0%) 4/7 (57.1%)
1/1 (100.0%) 0/2 (0.0%)
sia.
Table 3
Progression-free period and different assays as well as clinical parameters determined by uni- and multivariate Cox regression analyses. Floor of mouth and tongue were
considered to be high-risk locations, all other sites low-grade.
Univariate Cox regression analysis Multivariate Cox regression analysis
Variable Hazard ratio p-Value Hazard ratio
Corrected for:
Histopath. ICM FISH
Histopathology 6.3 <0.001 – 4.1 3.9
(2.32–17.25) (1.42–11.80) (1.31–11.50)
(p = 0.009) (p = 0.014)
DNA image cytometry 7.2 <0.001 5.4 – 4.2
(2.61–20.03) (1.82–15.77) (0.99–17.59)
(p = 0.002) (p = 0.052
FISH 6.8 <0.001 4.4 2.3 –
(2.53–18.30) (1.50–13.08) (0.57–9.27)
(p = 0.007) (p = 0.24)
Age 1.1 0.025
(1.01–1.10)
Sex 1.2 0.79
(0.42–3.11)
Location 3.2 0.047
(1.02–9.82)
Treatment 0.9 0.88
(0.29–2.93)
Alcohol 1.1 0.098
(0.98–1.23)
Tobacco 0.9 0.74
(0.32–2.73)
Pack years 1.0 0.29
(0.94–1.02)
CI = 95% conﬁdence interval.
Figure 2. Outcome of patients with leukoplakia of the oral cavity, based upon
histopathology. Comparing the combination of hyperplasia and mild dysplasia with
moderate and severe dysplasia results in HR = 6.3 (CI: 2.32–17.25; p < 0.001).
Table 4
Correlation-table ICM and FISH.
FISH
Diploid Aneuploid Total
ICM Diploid 76 3 79
Aneuploid 9 14 23
Total 85 17 102
Figure 3. Kaplan–Meier curve of the progression free proportion of based upon
ICM. HR = 7.2 (CI: 2.61–20.03; p < 0.001).
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aneuploid lesions without malignant progression for which subse-
quent leukoplakia specimens were available, showed transition
from aneuploid to diploid lesions (ICM-based) (Table 7). Addition-
ally, 6 (ICM-based) diploid initial leukoplakia without malignant
progression were followed by diploid leukoplakia on the same
location (FISH: 4 diploid; 2 not available). (data not shown). Five
patients treated for SCC developed new leukoplakia at the same
location (Table 6).
Figure 4. Kaplan–Meier curve of the progression free proportion of based upon
FISH. HR = 6.8 (CI: 2.53–18.30; p < 0.001).
Table 5
Level of association of ICM/FISH and different histopathological classes with
progression free survival.
DNA image
cytometry
Low-grade
(HP and D+)
High-grade
(D++ and D+++)
Histopathology
Diploid Reference N = 70 HR: 4.3 N = 9
(CI: 0.76–23.92)
(p = 0.101)
Aneuploid HR: 5.5 N = 12 HR: 22.0 N = 11
(CI: 1.37–21.96) (CI: 5.78–83.45)
(p = 0.016) (p < 0.001)
FISH analysis
Diploid Reference N = 74 HR: 9.04 N = 11
(CI: 2.21–36.9)
(p = 0.002)
Aneuploid HR: 10.1 N = 8 HR: 16.3 N = 9
(CI: 2.52–40.4) (CI: 3.90–68.18)
(p = 0.001) (p < 0.001)
Low-grade: combination of hyperplasia and mild dysplasia.
High-grade: combination of moderate and severe dysplasia.
Figure 5. Outcome of the ICM combined with histopathological subclasses.
Aneuploid low-grade combined with diploid high-grade: HR: 5.0 (CI: 1.41–17.89;
p = 0.013) (adjusted to diploid low-grade). Aneuploid high-grade HR: 21.9 (CI: 5.78–
83.18; p < 0.001) (adjusted to diploid low-grade). Aneuploid high-grade: HR: 4.4
(CI: 1.29–14.70; p = 0.018) (adjusted to aneuploid low-grade + diploid high-grade).
Table 6
Monitoring of related leukoplakia and malignant lesions that developed at the same
location over time.
Patient Initial
premalignancy
Intermediate
premalignancies
SCC Intermediate
premalignancies
Recurrent
SCC(s)
1 A D D A A
2 A AA A A
3 A A Aa
D
AaAA Ab
4 A A A Aa
5 D D D
6 D D DbDb
7 A A A A AA
8 A A Aa
9 D D D
Sequential ploidy scores represent mucosal disorders developed subsequently.
A = aneuploid lesion; D = diploid lesion. All values represent the same scores for
ICM and FISH except the cases marked with a(ICM is aneuploid and FISH diploid).
b FISH data not available.
Table 7
Monitoring of three patients with multiple leukoplakia without malignant
transformation.
Patient Biopsy
year
Biopsy site Histopathologic
diagnosis
ICM FISH Treatment
10. 1999 FOM front D+++ A A Laser
2000 FOM front D+++ D A Laser
2002 FOM front D+++ D D Laser
2006 End of follow-
up
11. 2004 Buccal
mucosa left
D+++ A A Surgery
2007 Buccal mucosa
left
D+++ D D Expectative
2010 End of follow
up
12. 1997 Trig.
Retromolare
D++ A D Expectative
1997 Right HP D A Expectative
Trig.
Retromolare
right
2001 Patient died
because of
heart failure
FOM = ﬂoor of mouth; Trig = trigonum; HP = hyperplasia; D++ = moderate dyspla-
sia; D+++ = severe dysplasia; D = diploid; A = aneuploid). Precursor lesions descri-
bed in bold is the ﬁrst biopsied lesion.
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In this study we analysed the added value of CI for the assess-
ment of the malignant potential of oral leukoplakia, using two
techniques (ICM and dual target FISH for chromosomes 1 and 7).
Previous studies established that histopathology is only partly suc-
cessful in predicting future behaviour of premalignant oral lesions
[8,9,11,12]. Data of the present study show that CI assessed by the
two different approaches is an independent prognosticator, provid-
ing valuable information in addition to the histopathological diag-
nosis. Combining these sources of information, three groups of
leukoplakia possessing respectively low, intermediate and high
risk for malignant transformation may be discriminated. Moreover,
it was found that CI detected by ICMmight be a useful tool to mon-
itor lesions over time. Generally, successive aneuploid premalig-
nancies ultimately resulted in (aneuploid) tumours, whereas a
shift from an aneuploid to a diploid status suggested a favourable
prognosis.
Our data concerning the prognostic value of the ploidy status of
oral leukoplakia are largely concordant with existing literature
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malignant progression in 43.5–47.1% (detected by ICM and FISH,
respectively). Similar percentages are found in other studies
[14,16,17]. Also in line with these studies, not all aneuploid leuko-
plakia transformed into malignancies. The results might be ex-
plained by the fact that these studies (including the present
study) are based upon retrospective data, harbouring different
intervention modalities (both radical and irradical) which ranged
from watchful waiting to surgical excision or laser ablation. As re-
ported by Torres-Rendon et al. [14] we observed that aneuploid
premalignancies are able to transform into SCC after a long time
span (in this study one case even after 12.6 years). Also, the fact
that diploid lesions may progress to SCC was repeatedly found
[14,16,17].
In this study, 37.5% of the developed SCC were found to be dip-
loid (FISH 56.3%), which may (at least partly) be explained by the
assessment method used. Previous studies found a large variability
in the percentage of diploid oral SCC (8–70%) [14,15,31,32]. The
lowest number of diploid SCC (8%) was found using a very sensitive
method (CV values as low as 1%) applying FCM [15]. In the present
study using ICM, CV values of approximately 5% were found, mak-
ing distinction between diploid and near-diploid populations haz-
ardous. Okafuji et al. concluded that sensitive techniques such as
comparative genomic hybridisation showed that all oral carcino-
mas were aneuploid, but that many are not detected as such by
techniques as FCM or ICM because of their detection limit
[33,35]. Another factor to consider when assessing ploidy status
is heterogeneity within oral lesions as reported before [33,34].
Baretton et al. showed increased sensitivity for ICM based ploi-
dy assessment, measuring ‘in situ’ in histological sections, rather
than isolating whole nuclei from parafﬁn blocks [32]. Apparently,
the possibility of selective sampling of nuclei in suspicious regions
enables detection of small aneuploid subpopulations, even when
applying a less sensitive measurement procedure. In the present
study, three of the initial premalignancies were diploid in ICM
but aneuploid in FISH. Besides sampling error an explanation
might be the inability of ICM (on whole nuclei) to detect small
aneuploid subpopulations in the biopsy specimen. In this study,
FISH analysis, which is also applied to selective tissue section areas,
identiﬁed in general less aneuploid cases compared to ICM, result-
ing in decreased sensitivity for predicting progression (with a cor-
responding increase in speciﬁcity). This may be explained by
sampling bias or by the fact that FISH only assesses copy number
variations of two centromere probes.
The results of Baretton et al. [32] are in accordance with our pre-
viously published data, in which ploidy assessment in tissue sec-
tions was combined with assessment of expression of biomarkers
Ki67, p53 and yH2AX [10]. Despite a sufﬁciently high sensitivity
of ICM and FISH also diploid precursor lesions as well as their sub-
sequent tumoursmay be found. It has been shown previously that a
minority of oral lesions follow an alternative genetic pathway, ulti-
mately resulting in an invasive phenotype not harbouring large
copy number alterations or chromosome instability [36]. This phe-
nomenon may also explain the results found in the present study.
Further study is therefore recommended. Combining ploidy data
with analysis of biomarkers relevant for this alternative pathway
evenmay yield additional information and increase sensitivity [10].
Subdivision of leukoplakia into three risk levels, based on the
combined histopathology and CI analysis may lead to a more
appropriate patient treatment. Both ICM as well as FISH are suit-
able for this approach. In this study, aneuploid high grade dysplasia
(comprising 11% of cases) had a progression free survival of
approximately 40% after 4 years (HR of 22.0 compared to low
histological grade diploid cases). Similar results were published
previously (HR of 19.3 for aneuploid high grade dysplasias, which
constituted 8% of the population) [17]. In comparison, 37.5% ofOSCC patients showed recurrence in a comparable time interval
after treatment [37]. Therefore, considering these lesions to be
similar to OSCC in terms of treatment options may be considered.
On the other end, diploid low grade leukoplakia are largely devoid
of malignant transformation (<3% after 6 years), justifying a ‘wait
and see’ policy. Especially for cases of mild and moderate dysplasia,
CI analysis may be used to tune clinical management. Results from
this study suggest that an aneuploid mild dysplasia is comparable
to a diploid moderate dysplasia in terms of progression free sur-
vival. On the other hand, a diploid mild dysplasia may be eligible
for a ‘wait and see’ policy whereas an aneuploid moderate dyspla-
sia may demand treatment comparable to an OSCC. In this way, CI
analysis may greatly reduce the number of cases of intermediate
malignant potential, which are inherently difﬁcult to manage.
With regard to the option of using CI analysis for monitoring
patients over time, promising results were obtained. Considering
the low number of cases for which data were available, however,
a prospective study is required to conﬁrm this hypothesis.
In conclusion, assessment of CI in oral leukoplakia yields inde-
pendent prognostic information, which may contribute to individ-
ual patient management. Different assays may be applied to
establish the CI status, having their own merits and weaknesses.
In the present study the combination of histopathology and CI
(both ICM and FISH) improved the assessment of the malignant po-
tential and may enable the monitoring of (treated) oral leukoplakia
over time. CI analysis can help to select patients with a high risk of
malignant progression and therefore may identify a subset of
leukoplakia suited for more strict follow-up as well as a group of
leukoplakia eligible for more aggressive treatment.Acknowledgements
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